These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1808157)

  • 1. Nephrotoxicity of low osmolality contrast media versus high osmolality media.
    Steinberg EP; Moore RD; Brinker JA; Fishman EK; Powe NR; Graziano SL; Gopalan R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S86; discussion S88-91. PubMed ID: 1808157
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.
    Moore RD; Steinberg EP; Powe NR; Brinker JA; Fishman EK; Graziano S; Gopalan R
    Radiology; 1992 Mar; 182(3):649-55. PubMed ID: 1535876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-osmolality versus high-osmolality contrast material.
    Korn WT; Bettmann MA
    Curr Opin Radiol; 1992 Apr; 4(2):9-15. PubMed ID: 1554592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective study of adverse reactions to contrast media administered intravenously--a comparison of low-osmolality and high-osmolality contrast media].
    Higashi S; Takizawa K; Suzuki S; Nagashima J; Tamura S; Ishikawa M; Obuchi M; Katayama M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1364-70. PubMed ID: 3237463
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast media-associated nephrotoxicity.
    Rudnick MR; Berns JS; Cohen RM; Goldfarb S
    Semin Nephrol; 1997 Jan; 17(1):15-26. PubMed ID: 9000546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and tolerance of roentgen contrast media].
    Schmiedel E
    Rontgenblatter; 1987 Jan; 40(1):1-8. PubMed ID: 3547606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contrast-media-induced nephrotoxicity].
    Adolph E; Chatterjee T; Ince H; Eckard H; Rehders T; Kische S; Drawert S; Petzsch M; Nienaber CA
    Dtsch Med Wochenschr; 2005 Oct; 130(42):2391-6. PubMed ID: 16235148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity.
    Goldfarb S; Spinler S; Berns JS; Rudnick MR
    Invest Radiol; 1993 Nov; 28 Suppl 5():S7-10; discussion S11-2. PubMed ID: 8282507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity and the role of contrast media.
    Aspelin P
    Radiat Med; 2004; 22(6):377-8. PubMed ID: 15648451
    [No Abstract]   [Full Text] [Related]  

  • 13. Low osmolar (non-ionic) contrast media versus high osmolar (ionic) contrast media in intravenous urography and enhanced computerized tomography: a cost-effectiveness analysis.
    Wangsuphachart S
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):664-76. PubMed ID: 1820658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial.
    Barrett BJ; Parfrey PS; McDonald JR; Hefferton DM; Reddy ER; McManamon PJ
    Radiology; 1992 Apr; 183(1):105-10. PubMed ID: 1549654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and determinants of adverse reactions induced by high-osmolality contrast media.
    Moore RD; Steinberg EP; Powe NR; White RI; Brinker JA; Fishman EK; Zinreich SJ; Smith CR
    Radiology; 1989 Mar; 170(3 Pt 1):727-32. PubMed ID: 2916027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.
    Scherberich JE; Fischer A; Rautschka E; Kollath J; Riemann H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():91-4. PubMed ID: 2568816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and late adverse reactions to low-osmolal contrast media.
    Mikkonen R; Kontkanen T; Kivisaari L
    Acta Radiol; 1995 Jan; 36(1):72-6. PubMed ID: 7833173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-osmolality and low-osmolality contrast agents.
    Parfrey PS; Barrett BJ
    N Engl J Med; 1992 Jul; 327(3):204-5. PubMed ID: 1608421
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal tolerance of iodinated low osmolality contrast agents. Clinical and experimental aspects].
    Deray G; Dubois M; Bellin MF; Grellet J; Jacobs C
    J Radiol; 1990; 71(6-7):439-44. PubMed ID: 2254874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.